Cellular Bioengineering Inc is categorized under Medical Research in Honolulu, HI and active since 2003.
Cellular Bioengineering Inc was established in 2003, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417113 by the NAICS.
If you are seeking more information, feel free to contact Hank Wuh, Chief Executive Officer at the company’s single location by writing to 650 Iwilei Road, Honolulu, Hawaii HI 96817 or by phoning (808) 949-2208. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cellular Bioengineering Inc |
| Contact Person: | Hank Wuh, Chief Executive Officer |
| Address: | 650 Iwilei Road, Honolulu, Hawaii 96817 |
| Phone Number: | (808) 949-2208 |
| Website Address: | eyegenix.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417113 |
| Share This Business: |
Cellular Bioengineering Inc was started in 2003 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417113. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Hank Wuh, Chief Executive Officer for inquiries that concern Cellular Bioengineering Inc by calling the company number (808) 949-2208, as your correspondence is most welcome. Additionally, the physical location of the single location of Cellular Bioengineering Inc can be found at the coordinates 21.31622,-157.86997 as well as the street address 650 Iwilei Road in Honolulu, Hawaii 96817.
For its online presence, you may visit Cellular Bioengineering Inc’s website at eyegenix.com and engage with its social media outlets through on Twitter and on Facebook.